The DOI matches its Crossref record; 36 of the 39 references it cites were found in a registry or an index.
Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study
Abstract
Background In China, depressive disorders have been estimated to be the second leading cause of years lived with disability. However, nationally representative epidemiological data for depressive disorders, in particular use of mental health services by adults with these disorders, are unavailable in China. The present study, part of the China Mental Health Survey, 2012-15, aims to describe the socioeconomic characteristics and the use of mental health services in people with depressive disorders in China.Methods The China Mental Health Survey was a cross-sectional epidemiological survey of mental disorders in a multistage clustered-area probability sample of adults of Chinese nationality (≥18 years) from 157 nationwide representative population-based disease surveillance points in 31 provinces across China. Trained investigators interviewed the participants with the Composite International Diagnostic Interview 3.0 to ascertain the presence of lifetime and 12-month depressive disorders according to DSM-IV criteria, including major depressive disorder, dysthymic disorder, and depressive disorder not otherwise specified. Participants with 12-month depressive disorders were asked whether they received any treatment for their emotional problems during the past 12 months and, if so, the specific types of treatment providers. The Sheehan Disability Scale (SDS) was used to assess impairments associated with 12-month depressive symptoms. Data-quality control procedures included logic check by computers, sequential recording check, and phone-call check by the quality controllers, and reinterview check by the psychiatrists. Data were weighted according to the age-sex-residence distribution data from China's 2010 census population survey to adjust for differential probabilities of selection and differential response, as well as to post-stratify the sample to match the population distribution.Findings 28 140 respondents (12 537 [44·6%] men and 15 603 [55·4%] women) completed the survey between July 22, 2013, and March 5, 2015. Ethnicity data (Han or non-Han) were collected for only a subsample. Prevalence of any depressive disorders was higher in women than men (lifetime prevalence odds ratio [OR] 1·44 [95% CI 1·20-1·72] and 12-month prevalence OR 1·41 [1·12-1·78]), in unemployed people than employed people (lifetime OR 2·38 [95% CI 1·68-3·38] and 12-month OR 2·80 [95% CI 1·88-4·18]), and in people who were separated, widowed, or divorced compared with those who were married or cohabiting (lifetime OR 1·87 [95% CI 1·39-2·51] and 12-month OR 1·85 [95% CI 1·40-2·46]). Overall, 574 (weighted % 75·9%) of 744 people with 12-month depressive disorders had role impairment of any SDS domain: 439 (83·6%) of 534 respondents with major depressive disorder, 207 (79·8%) of 254 respondents with dysthymic disorder, and 122 (59·9%) of 189 respondents with depressive disorder not otherwise specified. Only an estimated 84 (weighted % 9·5%) of 1007 participants with 12-month depressive disorders were treated in any treatment sector: 38 (3·6%) in speciality mental health, 20 (1·5%) in general medical, two (0·3%) in human services, and 21 (2·7%) in complementary and alternative medicine. Only 12 (0·5%) of 1007 participants with depressive disorders were treated adequately.Interpretation Depressive disorders in China were more prevalent in women than men, unemployed people than employed, and those who were separated, widowed, or divorced than people who were married or cohabiting. Most people with depressive disorders reported social impairment. Treatment rates were very low, and few people received adequate treatment. National programmes are needed to remove barriers to availability, accessibility, and acceptability of care for depression in China.Funding National Health Commission and Ministry of Science and Technology of People's Republic of China.Translation For the Chinese translation of the abstract see Supplementary Materials section.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, mental health services are few and still underutilized globally [4-6].”
From Conversational Agent Interventions for Mental Health Problems: Systematic Review and Meta-analysis of Randomized Controlled Trials (2023) · cites this paper as [4]
Citations
Cites
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
Self-citationKessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
Prevalence of mental disorders in China: a cross-sectional epidemiological study
Huang, Y., Wang, Y., Wang, H., Liu, Z., Yu, X., Yan, J., Yu, Y., Kou, C., Xu, X., Lu, J., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30511-x · Cited by 2,335
Self-citationRapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010
Yang, G., Wang, Y., Zeng, Y., Gao, G. F., Liang, X., Zhou, M., Wan, X., Yu, S., Jiang, Y., Naghavi, M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61097-1 · Cited by 1,984
Wang, P. S., Aguilar-Gaxiola, S., Alonso, J., Angermeyer, M. C., Borges, G., Bromet, E. J., Bruffaerts, R., de Girolamo, G., de Graaf, R., Gureje, O., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61414-7 · Cited by 1,655
Undertreatment of people with major depressive disorder in 21 countries
Thornicroft, G., Chatterji, S., Evans-Lacko, S., Gruber, M., Sampson, N., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J., Andrade, L., Borges, G., et al. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.116.188078 · Cited by 1,121
Self-citationAndrade, L., Caraveo‐anduaga, J. J., Berglund, P., Bijl, R. V., Graaf, R. D., Vollebergh, W., Dragomirecka, E., Kohn, R., Keller, M., Kessler, R. C., et al. (2003) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.138 · Cited by 1,068
Phillips, M. R., Zhang, J., Shi, Q., Song, Z., Ding, Z., Pang, S., Li, X., Zhang, Y., & Wang, Z. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60660-7 · Cited by 1,063
Self-citationMeng, Q., Fang, H., Liu, X., Yuan, B., & Xu, J. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00342-6 · Cited by 555
Kessler, R. C., Abelson, J., Demler, O., Escobar, J. I., Gibbon, M., Guyer, M. E., Howes, M. J., Jin, R., Vega, W. A., Walters, E. E., et al. (2004) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.169 · Cited by 489
Research works printed but not linked: 3
- 1986, A national 12-region psychiatric epidemiological study – methodology and results, Chin J Neurol Psychiatry, 19, 65
- Zhang, 1998, Epidemiological investigation on mental disorders in 7 areas of China, Chin J Psychiatry, 31, 69
- Wang, 2013, Reliability and validity of the Chinese version of WHO Disability Assessment Schedule 2.0 in mental disability assessment, Chin Ment Health J, 27, 121
Cited by
Sorted by citations
The path to healthy ageing in China: a Peking University–Lancet Commission
Chen, X., Giles, J., Yao, Y., Yip, W. C.-M., Meng, Q., Berkman, L. F., Chen, H., Chen, X., Feng, J., Feng, Z., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01546-x · Cited by 1,063
Self-citationYuan, M., Yang, B., Rothschild, G., Mann, J. J., Sanford, L. D., Tang, X., Huang, C., Wang, C., & Zhang, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01519-z · Cited by 246
He, Y., Yang, L., Qian, C., Li, T., Su, Z., Zhang, Q., & Hou, X. (2023) · Journal of Medical Internet Research · doi:10.2196/43862 · Cited by 213
“However, mental health services are few and still underutilized globally [4-6].”
Self-citationHe, Y., Yang, L., Zhu, X., Wu, B., Zhang, S., Qian, C., & Tian, T. (2022) · Journal of Medical Internet Research · doi:10.2196/40719 · Cited by 178
“However, the use of health services for depressive disorders in China has been rather limited, with the access rate of adequate treatment being less than 0.5% [29].”
InfluentialSelf-citationDu, X., Liao, J., Ye, Q., & Wu, H. Y. (2023) · Journal of Medical Internet Research · doi:10.2196/44514 · Cited by 107
“According to a report by the World Health Organization, there are more than 54 million patients with depressive disorder in China [8], accounting for approximately 17% of the global burden of mental disorders [9], and the lifetime prevalence of depressive disorder in Chinese adults is 6.8% [10].”
InfluentialAutomatic depression recognition by intelligent speech signal processing: A systematic survey
Wu, P., Wang, R., Lin, H., Zhang, F., Tu, J., & Sun, M. (2022) · CAAI Transactions on Intelligence Technology · doi:10.1049/cit2.12113 · Cited by 104
Zhang, T., Kan, L., Jin, C.-B., & Shi, W.-M. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.12.058 · Cited by 83
Self-citationInformation, awareness, and mental health: Evidence from air pollution disclosure in China
Xie, T., Yuan, Y., & Zhang, H. (2023) · Journal of Environmental Economics and Management · doi:10.1016/j.jeem.2023.102827 · Cited by 93
Gut microbiota variations in depression and anxiety: a systematic review
Cao, Y., Cheng, Y., Pan, W., Diao, J., Sun, L., & Meng, M. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06871-8 · Cited by 80
“Studies were excluded if they met the following criteria: [1] Patients with depression or anxiety complicated with irritable bowel syndrome, inflammatory bowel disease or other diseases; [2] Data cannot be extracted; [3] Full texts were not available.”
InfluentialSelf-citationWang, H., Jin, M., Xie, M., Yang, Y., Xue, F., Li, W., Zhang, M., Li, Z., Li, X., Jia, N., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.11.072 · Cited by 80
Universal health coverage in China part 1: progress and gaps
Yip, W. C.-M., Fu, H., Jian, W., Liu, J., Pan, J., Xu, D., Yang, H., & Zhai, T. (2023) · The Lancet Public Health · doi:10.1016/s2468-2667(23)00254-2 · Cited by 79
Zhang, Z., Chen, X., Wu, S., Chen, X., Wang, X., Liu, C., Zeng, N., Liu, Y., Huo, T., Liu, X., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120299 · Cited by 87
Self-citationWang, Z., Luo, Y., Zhang, Y., Chen, L., Zou, Y., Xiao, J. F., Min, W., Yuan, C., Ye, Y., Li, M., et al. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.03.018 · Cited by 80
Self-citationProbiotics for the treatment of depression and its comorbidities: A systemic review
Gao, J., Zhao, N., Cheng, Y., Lei, W., Wang, Y., Liu, X., Zheng, N., Shao, L., Chen, X., Sun, Y., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1167116 · Cited by 81
“TYPE Review PUBLISHED 17 April 2023 DOI 10.3389/fcimb.2023.1167116 Probiotics for the treatment of depression and its comorbidities: A systemic review Jie Gao1†, Longyou Zhao2†, Yiwen Cheng1,3†, Wenhui Lei3,4, Yu Wang1, Xia Liu5, Nengneng Zheng6, Li Shao7, Xulei Chen8, Yilai Sun8, Zongxin Ling 1,3* and Weijie Xu8* 1Co…”
BackgroundInfluentialXie, X., Li, Y., Liu, J., Zhang, L., Sun, T., Zhang, C., Liu, Z., Liu, J., Li, W., Gong, X., et al. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115638 · Cited by 66
“In the Chinese context, depression has ascended to become the second principal contributor to disability-adjusted life years (DALYs) lost (Lu et al., 2021).”
BackgroundHan, S.-S., Zhang, Y.-S., Zhu, W., Ye, Y.-P., Li, Y.-X., Meng, S., Feng, S., Han, L., Cui, Z.-L., Zhang, Y., et al. (2025) · BMC Public Health · doi:10.1186/s12889-025-22443-7 · Cited by 78
“This finding is consistent with previous studies of a sample of Chinese university students [27, 61], suggesting the need for effective management of anxiety symptoms in the treatment of depressive disorders, and vice versa.”
Self-citationChen, T.-J., Dong, B., Dong, Y., Li, J., Ma, Y., Liu, D., Zhang, Y., Xing, Y., Zheng, Y., Luo, X., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02894-5 · Cited by 76
Self-citationExosomes in brain diseases: Pathogenesis and therapeutic targets
Si, Q., Wu, L., Pang, D., & Jiang, P. (2023) · MedComm · doi:10.1002/mco2.287 · Cited by 66
“139 The currently available treatments for depression include medication, psychotherapy, and physical therapy.”
BackgroundJing, R., Jin, G., Guo, Y., Zhang, Y., & Li, L. (2022) · Computers in Human Behavior · doi:10.1016/j.chb.2022.107480 · Cited by 66
Self-citationXia, F., Li, Q., Luo, X., & Wu, J. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.939758 · Cited by 61
The correlation of Esketamine with specific adverse events: a deep dive into the FAERS database
Jiang, Y., Du, Z., Shen, Y., Zhou, Q., & Zhu, H. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01732-5 · Cited by 65
“Even more concerning, 15% of patients with severe depression exhibit suicidal behaviors, and 3.4% eventually succumb to suicide, leading to a significant socio-familial burden [1–3].”
InfluentialHe, H., He, H., Mo, L., You, Z., & Zhang, J. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.10.031 · Cited by 62
Ding, Y., Chen, L., & Zhen, Z. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.996606 · Cited by 59
Chen, D., Yang, H., Yang, L., Tang, Y., Zeng, H., He, J., Chen, W., Qu, Y., Hu, Y., Xu, Y., et al. (2023) · British Journal of Anaesthesia · doi:10.1016/j.bja.2023.10.015 · Cited by 60
Self-citationWang, Y., Qin, C., Chen, H., Liang, W., Liu, M., & Liu, J. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.01.086 · Cited by 60
Self-citationWu, B., Zhang, H., Chen, J., Chen, J., Liu, Z., Cheng, Y., Yuan, T., & Peng, D. (2023) · General Psychiatry · doi:10.1136/gpsych-2022-100946 · Cited by 55
Zhu, X., Wang, Y., Luo, Y., Ding, R., Shi, Z., & He, P. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-05248-y · Cited by 56
“In China, the lifetime prevalence of depression among individuals aged 50–64 is 7.8%, while among adults aged 65 and above, the prevalence is approximately 7.3% [23].”
BackgroundInfluentialHe, Z.-F., Tan, W., Ma, H., Shuai, Y., Shan, Z., Zhai, J., Qiu, Y., Zeng, H., Chen, X., Wang, S., et al. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.11.022 · Cited by 57
Tian, F., Yang, H., & Pan, J. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.05.001 · Cited by 50
Chen, S., Sun, H., Song, Y., Zhang, M., Huang, W., Zhao, C., Wang, Y., Wang, J., Meng, H., Zhou, L., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.06.067 · Cited by 49
Self-citationDing, K., Wang, S., Xu, W., Lin, L., Liao, D., Chen, H., Tan, W., Huang, J., Hou, C., & Jia, F. (2022) · Asia-Pacific Psychiatry · doi:10.1111/appy.12520 · Cited by 47
“The China Mental Health Survey demonstrated that the treatment rate of participants with 12-month depressive disorder was 9.5%, and the rate of receiving adequate treatments was only 0.5% (Lu et al., 2021).”
InfluentialSelf-citationSocioeconomic inequality in depression and anxiety and its determinants in Iranian older adults
Azizabadi, Z., Aminisani, N., & Emamian, M. H. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04433-w · Cited by 47
“Other studies have also reported the role of age in socio-economic inequality in mental health, some of them have reported that anxiety, depressive symptoms and mental health worsen with age [18, 19, 40].”
BackgroundWang, B., Li, M., Haihambo, N. P., Qiu, Z., Sun, M., Guo, M., Zhao, X., & Han, C. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.03.145 · Cited by 46
Self-citationShan, W., Peng, X., Tan, W., Zhou, Z., Xie, H., & Wang, S. (2024) · Sleep Medicine · doi:10.1016/j.sleep.2024.01.023 · Cited by 44
Qiu, W., Cai, A., Li, L., & Feng, Y. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003609 · Cited by 45
“The issue is much more severe in the middle-aged and older population, with nearly 14% of people aged more than 55 years suffering from depression in United States [4]. the population aging and rapid development of the economy, China has been subjected to such public health threats as well [5].”
BackgroundSelf-citationHuang, J., & Wang, X. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.03.081 · Cited by 41
Luo, M.-M., Hao, M., Li, X.-H., Liao, J., Wu, C.-M., & Wang, Q. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1326582 · Cited by 40
Han, T., Han, M., Moreira, P., Song, H., Li, P., & Zhang, Z. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1099260 · Cited by 40
Leveraging Domain Knowledge to Improve Depression Detection on Chinese Social Media
Guo, Z., Ding, N., Zhai, M., Zhang, Z., & Li, Z. (2023) · IEEE Transactions on Computational Social Systems · doi:10.1109/tcss.2023.3267183 · Cited by 40
The consequences of health shocks on households: Evidence from China
Wang, Y., Jin, Z., & Yuan, Y. (2023) · China Economic Review · doi:10.1016/j.chieco.2023.101969 · Cited by 41
Opportunities and Challenges for Large Language Models in Primary Health Care
Qin, H., & Tong, Y. (2025) · Journal of Primary Care & Community Health · doi:10.1177/21501319241312571 · Cited by 47
“35 Soulchat 36 can offer humanized psychological counseling services through multi-turn empathetic dialogues, providing a convenient support ave-nue for those who cannot access mental health services in a timely manner.”
Zhang, H., Jiang, F., Li, L., Liu, X., & Yan, J. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.10.085 · Cited by 41
Self-citationKetamine and Electroconvulsive Therapy for Treatment-Refractory Depression
Huang, X., & Zheng, W. (2023) · ALPHA PSYCHIATRY · doi:10.5152/alphapsychiatry.2023.231358 · Cited by 38
Detecting depression based on facial cues elicited by emotional stimuli in video
Hu, B., Tao, Y., & Yang, M. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107457 · Cited by 36
Effect of music therapy on older adults with depression: A systematic review and meta-analysis
Wang, M., Wu, J., & Yan, H. (2023) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2023.101809 · Cited by 36
Xu, R., Liu, Y., Mu, T., Ye, Y., & Xu, C. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.954416 · Cited by 36
Antioxidant Carbon Dots Nanozymes Alleviate Stress-induced Depression by Modulating Gut Microbiota
Jia, H., Gong, J., Hu, Z., Wen, T., Li, C., Chen, Y., Huang, J., & He, W. (2024) · Langmuir · doi:10.1021/acs.langmuir.4c02481 · Cited by 36
Zhang, M., Mo, J., Zhang, H., Tang, Y., Guo, K., OuYang, X., Huang, L., Zhong, X., & Ning, Y. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.11.027 · Cited by 37
Gkintoni, E., Vantarakis, A., & Gourzis, P. (2025) · Medicina · doi:10.3390/medicina61061003 · Cited by 40
Liao, D.-D., Dong, M., Ding, K., Hou, C., Tan, W., Ke, Y.-F., Jia, F., & Wang, S. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.02.069 · Cited by 35
Self-citationLv, X., Sun, S., Wang, J., Chen, H., Li, S., Hu, Y., Yu, M., Zeng, Y., Gao, X., Xu, Y., et al. (2022) · Nutrients · doi:10.3390/nu14235062 · Cited by 34
“In China, depressive disorder ranks second in the list of causes of disability [2].”
BackgroundSelf-citationSocial determinants of health and gender differences in depression among adults: A cohort study
Zhou, F., He, S., Shuai, J., Deng, Z., Wang, Q., & Yan, Y. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115548 · Cited by 32
Self-citationBen‐Arye, E., Lopez, G., Rassouli, M., Ortiz, M., Cramer, H., & Samuels, N. (2024) · Current Psychiatry Reports · doi:10.1007/s11920-024-01515-2 · Cited by 32
Singla, R., Mishra, A., & Cao, R. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02120-8 · Cited by 35
Huang, B., Wu, Y., Li, C., Tang, Q., & Zhang, Y. (2023) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2022.10.004 · Cited by 33
“5% of the patients are fully treated (Huang et al., 2019; Lu et al., 2021).”
BackgroundSelf-citationYing, Y., Ji, Y., Kong, F., Wang, M., Chen, Q., Wang, L., Hou, Y., Yu, L., Zhu, L., Miao, P., et al. (2022) · Psychological Medicine · doi:10.1017/s0033291722000599 · Cited by 31
“Lu et al. (2021) found that the treatment rates of sD might be very low, and a few individuals receive adequate treatment in China, underscoring the importance of national programs to eliminate barriers to availability, accessibility, and acceptability of care for sD in China.”
BackgroundSelf-citationAcupuncture for Major Depressive Disorder: A Data Mining-Based Literature Study
Tu, M., Xiong, S., Lv, S., Wu, X., Hu, H., Hu, R., Fang, J., & Shao, X. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s405728 · Cited by 30
“45 LR3 (213), SP6 (194), ST36 (141), KI3 (80), ST40 (52), LR2 (40), GB34 (26), KI6 (17), SP9 (16), GB43 (14), ST44 (13), KI1 (12), SP4 (12), SP10 (9), SP1 (9), BL62 (8), ST37 (7), SP3 (6), LR8 (6), GB40 (3), GB41 (2), SP5 (2), LR5 (2), LR6 (2), GB39 (2), ST34 (1), LR7 (1), ST32 (1), ST41 (1), KI4 (1), LR1 (1), GB37 (1…”
InfluentialLu, G., Xiao, S., He, J., Xie, W., Ge, W., Meng, F., Yang, Y., Yu, S., & Liu, R. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1122626 · Cited by 34
“5% of patients received adequate treatment (3).”
Self-citationShao, X., Wang, Y., Geng, Z., Liang, G., Zhu, X., Liu, L., Meng, M., Duan, L., & Zhu, G. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03126-0 · Cited by 32
Bian, X., Zhou, N., Zhao, Y. V., Fang, Y., Li, N., Zhang, X., Wang, X., Li, Y., Wu, J., & Zhou, T. (2022) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13517 · Cited by 33
“Depression is a psychiatric illness that severely influences the mood, causing anhedonia, and anxiety in patients.(1,2) In addition, depression impairs quality of life and makes patients feel sadness, hopelessness, and helplessness.”
BackgroundKong, X., Wu, Y., Wang, X., Sun, Y., Chen, K., Li, Q., & Li, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15889 · Cited by 32
Self-citationFertility history and intentions of married women, China
Li, Q., Yang, R., Zhou, Z., Qian, W., Zhang, J., Wu, Z., Jin, L., Wu, X., Zhang, C., Zheng, B., et al. (2024) · Bulletin of the World Health Organization · doi:10.2471/blt.23.289736 · Cited by 31
“20 Taylor series linearization was used to estimate standard errors and to determine 95% confidence intervals (95% CIs) for prevalence estimates.”
MethodSelf-citationExamining the mental health services among people with mental disorders: a literature review
Gao, Y., Burns, R. A., Leach, L., Chilver, M. R., & Butterworth, P. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05965-z · Cited by 34
Working memory function in patients with major depression disorder: A narrative review
Chen, L., Wang, Q., & Xu, T. (2022) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2811 · Cited by 35
The relationship between BMI and depression: a cross-sectional study
Cui, H., Xiong, Y., Wang, C., Ye, J., & Zhao, W. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1410782 · Cited by 28
Guo, X., Lin, L., Qin, K., Li, J., Chen, W., & Guo, V. Y. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.08.082 · Cited by 28
Zhou, Q., Eggleston, K. N., & Liu, G. G. (2024) · Health Policy and Planning · doi:10.1093/heapol/czae031 · Cited by 28
“Only 9.5% with 12-month depressive disorders were treated at all, and only 0.5% were treated adequately (Lu et al ., 2021).”
BackgroundInfluentialPeripheral mitochondrial DNA as a neuroinflammatory biomarker for major depressive disorder
Ye, J., Duan, C., Han, J., Chen, J., Sun, N., Li, Y., Yuan, T., & Peng, D. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01878 · Cited by 30
Ju, K., Lu, L., Liao, W., Yang, C., Xu, Z., Wang, W., Li, Z., & Pan, J. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.159434 · Cited by 27
Lin, Z., Cheng, L., Han, X., Wang, H., Liao, Y., Guo, L., Shi, J., Fan, B., Teopiz, K. M., Jawad, M. Y., et al. (2023) · Journal of Medical Internet Research · doi:10.2196/42786 · Cited by 25
“On the one hand, the prevalence of MDD has been reported to be higher among women [6].”
InfluentialSelf-citationHan, D. K., Zhao, Z., Mao, T., Gao, M., Yang, X., & Gao, Y. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70150 · Cited by 30
Hao, R., Jin, H., Zuo, J., Wu, Y., Sun, X., & Hu, J. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.01.097 · Cited by 28
Self-citationThe roles of extracellular vesicles in major depressive disorder
Li, Y., Gui, Y., Zhao, M., Chen, X., Li, H., Chen, T., Zhao, H., Jiang, C., Xu, P., Zhang, S., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1138110 · Cited by 28
Lu, Z., Yu, D., Wang, L., & Fu, P. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.10.050 · Cited by 27
Self-citationXie, Y., Ma, M., & Wang, W. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-04048-0 · Cited by 25
“Considering depressive symptoms are easier and more convenient to diagnose than clinical depression, and a considerable number of older patients with MDD are underdiagnosed [9], the measures of depressive symptoms are used more frequently in mental health primary care and other epidemiological investigations to identi…”
BackgroundPrevalence and predictors of depression among women in Afghanistan: a cross-sectional study
Neyazi, A., Haidarzada, A. S., Rangelova, V., Erfan, A., Bashiri, B., Neyazi, M., Faizi, N., Ünlü, H. K., Saokaew, S., & Griffiths, M. D. (2023) · Discover Psychology · doi:10.1007/s44202-023-00068-4 · Cited by 24
“Different studies have estimated consistently higher prevalence of depressive disorders among females than in males [24, 25].”
BackgroundMy Story of Depression: A Content Analysis of Autobiographic Videos on Douyin
Li, J., Tang, L., & Pu, Y. (2023) · Health Communication · doi:10.1080/10410236.2023.2191887 · Cited by 23
“Past research on stigma and stigma communication has shown that such internal attribution can lead to increased stigma (Huang et al., 2021).”
BackgroundInfluentialHe, X., Hu, J., Peng, X., Zhao, L., Zhou, D., Ma, L., Zhang, Z.-Y., Tao, W., Liu, X., Kuang, L., et al. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.11.018 · Cited by 24
Do the therapeutic effects of psilocybin involve actions in the gut?
Reed, F. M., & Foldi, C. J. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.12.007 · Cited by 26
Song, Y., Liu, H., & Liu, Y. (2024) · PLoS ONE · doi:10.1371/journal.pone.0302939 · Cited by 25
Chen, Z., Wu, F., Shi, Y., Guo, Y., Xu, J., Liang, S., Huang, Z., He, G., Hu, J., Zhu, Q., et al. (2024) · Environmental Health Perspectives · doi:10.1289/ehp13947 · Cited by 24
Self-citationChen, Z., Tang, Y., Liu, X., Li, W., Hu, Y., Hu, B., Xu, T., Zhang, R., Xia, L., Zhang, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-55008-0 · Cited by 27
“The SDS was one of the most widely-used tools to measure depressive symptoms or activities, with prominently good psychometric merits in the general population 112,113 .”
Self-citationXie, X., Shi, Y., Ma, L., Yang, W., Pu, J., Shen, Y., Liu, Y., Zhang, H., Lv, F., & Hu, L. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.12.020 · Cited by 24
Yuan, W., Chen, L., Wu, Y., Su, B., Liu, J., Zhang, Y., Chen, M., Ma, Y., Guo, T., Wang, X., et al. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.06.029 · Cited by 26
Self-citationZheng, Z., Zhao, W., Zhou, Q. F., Yang, Y., Chen, S., Hu, J., Jiang, W., Zhang, W., Cai, J., & Qiu, J. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.07.107 · Cited by 29
Wang, X., Cao, X., Yu, J., Jin, S., Li, S., Chen, L., Liu, Z., Ge, X., & Lu, Y. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05609-2 · Cited by 30
“It was estimated that the prevalence of depression among adults in China is 6.8% through the China Mental Health Survey [8].”
BackgroundInfluentialSelf-citationLi, M., Gao, W., Zhang, Y., Luo, Q., Xiang, Y., Bao, K., & Zaki, N. M. (2023) · BMC Public Health · doi:10.1186/s12889-023-17025-4 · Cited by 23
“Despite these challenges, the treatment rates of depressive disorders in China have been reported to be very low, with only a small number of individuals receiving sufficient treatment in 2019 [11].”
BackgroundSelf-citationChina initiates depression screening in children and adolescents
Kong, L., Lai, J., & Hu, S. (2022) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00479-x · Cited by 23
Xi, G., Jiang, W., Liao, J., Li, J., & Yang, L. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.02.064 · Cited by 24
Dong, W., Liu, Y., Sun, J., Liu, Y., Sun, Z., & Bai, R. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.831188 · Cited by 23
“In addition, more willingness to admit symptoms than before (22), may also contribute to the increase of schizophrenia incidence.”
BackgroundCao, L. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.916329 · Cited by 25
Zhu, Y., Li, C.-L., Wu, T., Wang, Y., Hua, R., Ma, Y.-J., & Xie, W. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.09.128 · Cited by 20
Self-citationLu, Z., Sun, Y., Liao, Y., Kang, Z., Feng, X., Zhao, G., Sun, J., Zhang, Y., & Yue, W. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.04.079 · Cited by 25
Self-citationAssociation of triglyceride-glucose index with major depressive disorder: A cross-sectional study
Jin, M., Lv, P., Liang, H., Teng, Z., Gao, C., Zhang, X., Ni, A., Cui, X., Meng, N., & Li, L. (2023) · Medicine · doi:10.1097/md.0000000000034058 · Cited by 23
“[6,7] MDD has been the second leading cause of disability-adjusted life years in China since 2010.[8] Current treatments for depression are symptom-suppressing.”
BackgroundSelf-citationLong, Y., Li, X., Cao, H., Zhang, M., Lü, B., Huang, Y., Liu, M., Xu, M., Liu, Z., Yan, C., et al. (2023) · Psychological Medicine · doi:10.1017/s0033291723002234 · Cited by 26
“Major depressive disorder (MDD) is one of the most common psychiatric disorders and a leading cause of disability worldwide (Hasin et al., 2018; Iancu, Wong, Rhebergen, van Balkom, & Batelaan, 2020; Lu et al., 2021).”
Self-citationHe, W., Zhang, S., Qi, Z., & Liu, W. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107201 · Cited by 23
Machine learning algorithms to predict depression in older adults in China: a cross-sectional study
Song, Y. L. Q., Chen, L., Liu, H., & Liu, Y. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1462387 · Cited by 23
Yan, N., Zhang, C., Wang, Y., Wang, Y., Luo, Y., Wang, Y., Shiferaw, B. D., Mackay, L. E., Wang, J., Tang, J. T., et al. (2025) · BMC Psychology · doi:10.1186/s40359-025-02349-0 · Cited by 22
Shen, J., Zhu, K., Ma, R., Hu, W., Tan, X., Deng, N., Zhou, X., Li, C., Li, C., Xu, C., et al. (2025) · Information Fusion · doi:10.1016/j.inffus.2025.103772 · Cited by 24
Self-citationWang, G., Xiao, L., Ren, H., Simonsen, K., Ma, J., Xu, X., Guo, P., Wang, Z., Bai, L., Heldbo Reines, E., et al. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s358253 · Cited by 22
“As the second-leading cause of years lived with disability in China, MDD imposes a substantial burden on patients, impairing both functioning and quality of life.(6,7) MDD also exacts a significant societal burden through both direct and indirect costs.”
BackgroundSelf-citation
Metadata
- Authors
- Lu, J., Xu, X., Huang, Y., Li, T., Ma, C., Xu, G., Yin, H., Xu, X., Ma, Y., Wang, L., Huang, Z., Yan, Y., Wang, B., Xiao, S., Zhou, L., Li, L., Zhang, Y., Chen, H., Zhang, T., Yan, J., Ding, H., Yu, Y., Kou, C., Shen, Z., Jiang, L., Wang, Z., Sun, X., Xu, Y., He, Y., Guo, W., Jiang, L., Li, S., Pan, W., Wu, Y., Li, G., Jia, F., Shi, J., Shen, Z., & Zhang, N.
- Affiliations
- Urumqi 4th People's Hospital (CN)
- Peking University (CN)
- Sichuan University (CN)
- Tianjin Anding Hospital (CN)
- Chinese Center For Disease Control and Prevention (CN)
- Air Force Medical University (CN)
- Central South University (CN)
- Jilin University (CN)
- First Affiliated Hospital of Kunming Medical University (CN)
- Ningxia Medical University (CN)
- Shanghai Jiao Tong University (CN)
- Qinghai No.3 People's Hospital (CN)
- Soochow University (CN)
- Nanjing Medical University (CN)
- Hangzhou Seventh Peoples Hospital (CN)
- Nanjing Brain Hospital (CN)
- Corresponding author
- Huang, Yueqin
- ORCID
- Xu, Xiufeng
- Huang, Yueqin
- Li, Tao
- Ma, Chao
- Xu, Guangming
- Yin, Huifang
- Ma, Yanjuan
- Wang, Limin
- Wang, Bo
- Xiao, Shuiyuan
- Zhou, Liang
- Li, Lingjiang
- Zhang, Yan
- Chen, Hongguang
- Zhang, TingTing
- Yan, Jie
- Ding, Hua
- Yu, Yaqin
- Kou, Changgui
- Shen, Zonglin
- Wang, Zhizhong
- Sun, Xian
- Xu, Yifeng
- He, Yanling
- Guo, Wanjun
- Jiang, Lijun
- Li, Shengyan
- Pan, Wen
- Wu, Yue
- Li, Guohua
- Shi, Jianfei
- Shen, Zhongxia
- Zhang, Ning
- Venue
- The Lancet Psychiatry
- Publisher
- Elsevier BV
- Published
- 2021-11
- Volume
- 8
- Issue
- 11
- Pages
- 981-990
- ISSN
- 2215-0366 (ISSN-L)
- OpenAlex
- W3201200719
- Cited by
- 844
- References
- 39
- Citations by year
- 2026: 150 · 2025: 228 · 2024: 211 · 2023: 166 · 2022: 82 · 2021: 7
- FWCI
- 114.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- The Lancet Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Key Research and Development Program of China (2017YFC0907800, 2017YFC0907801)
- Center for Mental Health Services
- Ministry of Science and Technology of the People's Republic of China (2012BAI01B01, 2015BAI13B00)
- Ministry of Health of the People's Republic of China (201202022)
- School of Medicine, Shanghai Jiao Tong University
- Peking University
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
- Keywords
- depressive disorders, prevalence, mental health service utilization, treatment seeking, major depressive disorder, dysthymia, depressive symptoms, socioeconomic factors, unemployment, disability, China, gender differences, lifetime prevalence, 12-month prevalence, treatment providers, Han Chinese, ethnic minorities, mental health policy, mental health service planning, mental health professionals
- MeSH terms
- Global Burden of Disease, Adult, Aged, China, Cross-Sectional Studies, Major Depressive Disorder, Female, Humans, Male, Mental Health Services, Middle Aged, Population Surveillance, Surveys and Questionnaires, Risk Factors, Socioeconomic Factors, Prevalence, Age Distribution, Sex Distribution, Dysthymic Disorder, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
